MedPath

Evaluating Two Multifocal Daily Disposable Contact Lenses

Not Applicable
Completed
Conditions
Presbyopia
Interventions
Device: Control Lens
Device: Test Lens
Registration Number
NCT05579886
Lead Sponsor
Coopervision, Inc.
Brief Summary

The objective of the study was to adapt existing multifocal soft lens wearers to a Control Lens for at least 2 weeks and then evaluate the success of switching them to the Test Lens, with a review after 2 weeks.

Detailed Description

This prospective, bilateral eye, open label, non-randomized study compared the performance of 2 different designs of daily disposable multifocal contact lenses.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria

A person was eligible for inclusion in the study if he/she:

  1. Was at least 42 years of age and had full legal capacity to volunteer;
  2. Had read and signed an information consent letter;
  3. Self-reported having had a full eye examination in the previous two years;
  4. Anticipated being able to wear the study lenses for at least 8 hours a day, 5 days a week;
  5. Was willing and able to follow instructions and maintain the appointment schedule;
  6. Habitually wore multifocal soft contact lenses, for the past 3 months minimum (NOTE: the habitual contact lens type was restricted such that no more than one third were to be the clariti 1 day multifocal and no more than one third were to be MyDay multifocal (this included their equivalent private label brand name);
  7. Had refractive astigmatism no higher than -0.75DC in each eye;
  8. Was presbyopic and required a reading addition of at least +0.75D and no more than +2.50D in each eye;
  9. Could be fit and achieved binocular distance vision of at least 20/30 Snellen (or +0.20 logMAR) which participants also deemed to be 'acceptable', with the available study lens parameters (powers +4.00 to -6.00DS)
Exclusion Criteria

A person was excluded from the study if he/she:

  1. Was participating in any concurrent clinical or research study;
  2. Had any known active ocular disease and/or infection that contraindicated contact lens wear;
  3. Had a systemic condition that in the opinion of the investigator may have affected a study outcome variable;
  4. Was using any systemic or topical medications that in the opinion of the investigator may have affected contact lens wear or a study outcome variable;
  5. Had known sensitivity to the diagnostic sodium fluorescein to be used in the study;
  6. Self-reported as pregnant, lactating or planning a pregnancy at the time of enrolment;
  7. Had undergone refractive error surgery or interocular surgery.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Control LensControl LensAll participants wore the Control Lens for 2 weeks (Period 1)
Test LensTest LensAll participants wore the Test Lens for 2 weeks (Period 2)
Primary Outcome Measures
NameTimeMethod
Comfort Just After Lens Insertion2 weeks

Subjective rating measured on a scale of 0-10, 0.5 steps, where 0=Painful, 10=Can't feel the lenses.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (5)

Nittany Eye Associates

🇺🇸

State College, Pennsylvania, United States

Sacco Eye Group

🇺🇸

Vestal, New York, United States

Coan Eye Care & Optical Boutique

🇺🇸

Ocoee, Florida, United States

ProCare Vision Center

🇺🇸

Granville, Ohio, United States

Kannarr Eye Care

🇺🇸

Pittsburg, Kansas, United States

© Copyright 2025. All Rights Reserved by MedPath